S. R. Nalamachu, MD, N. Parikh, L. Dillaha, MD, and R. Rauck, MD, “Lack of correlation between the effective dose of fentanyl sublingual spray for breakthrough cancer pain and the around-the-clock opioid dose”, J of Opioid Management, vol. 10, no. 4, pp. 247–254, Jul. 2014.